Xeris Biopharma Holdings Inc (XERS) Stock Price, Quote, News & History

XERSNASDAQ
$6.15
0.264.41%
At close: Jun 4, 5:00 PM EST
$6.15
N/A
After Hours: 4:32 PM EST
Loading...

Key Statistics

Open
$5.96
Close
$6.15
Volume / Avg.
2.40M / 1.69M
Day Range
$5.93 - $6.17
52 Wk Range
4.30 - 10.08
Market Cap
$1.06B
P/E Ratio
84.07
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
7.41%
Days to Cover
5.8
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
48.53M
Investing Cash Flow (TTM)
-1.01M
Financing Cash Flow (TTM)
5.69M
Free Cash Flow (TTM)
47.52M
Capital Expenditure (TTM)
-1.01M
Net Change in Cash (TTM)
53.21M

Analyst Trends and Forecast

1
Dec 25
1
Jan
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.19B
PE Ratio (TTM)
84.07
PE Ratio (FWD)
73.53
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.35
PB Ratio (TTM)
78.09
Earnings Yield % (TTM)
1.19%
Earnings Yield % (FWD)
1.36%
EV / EBITDA (TTM)
21.76
Price / EBITDA (TTM)
19.72
Price / Free Cash Flow (TTM)
22.17
Book Value / Share
$0.08

Company Debt

Total Debt
$221.22M
LT Debt
$221.22M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$111.75M
Debt to Equity
19.87
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$5.96
Close
$6.15
Volume / Avg.
2.40M / 1.69M
Day Range
$5.93 - $6.17
52 Wk Range
4.30 - 10.08
Market Cap
$1.06B
P/E Ratio
84.07
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
7.41%
Days to Cover
5.8

About

Sector
Health Care
Industry
Pharmaceuticals
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Xeris Biopharma Holdings (XERS) stock?

A

You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xeris Biopharma Holdings (XERS) competitors?

A

There are no as such competitors for Xeris Biopharma Holdings.

Q

What is the forecast, or price target, for Xeris Biopharma Holdings (XERS) stock?

A

Xeris Biopharma Holdings has a consensus price target of $9.28.

Q

What is the current price for Xeris Biopharma Holdings (XERS)?

A

The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $6.15 last updated June 4, 2026 at 4:32 PM EDT.

Q

Does Xeris Biopharma Holdings (XERS) pay a dividend?

A

There are no upcoming dividends for Xeris Biopharma Holdings.

Q

When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?

A

Xeris Biopharma Holdings does not have any upcoming earnings scheduled.

Q

Is Xeris Biopharma Holdings (XERS) going to split?

A

There is no upcoming split for Xeris Biopharma Holdings.

Q

What sector and industry does Xeris Biopharma Holdings (XERS) operate in?

A

Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.